Lubomir Sokol MD

Hematology•Tampa, FL

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Request appointment

12902 USF Magnolia DriveTampa, FL 33612
Book by Phone+1(229) 597-8627
Fax+1 813-745-5959

Overview of Dr. Sokol

Dr. Lubomir Sokol is a hematologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and Tampa General Hospital. He received his medical degree from University Karlovy, Lek Fak Ii and has been in practice 45 years. Dr. Sokol accepts several types of health insurance, listed below. He is one of 60 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 8 doctors at Tampa General Hospital who specialize in Hematology. He has more than 100 publications and over 500 citings.

Education & Training

University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2000 - 2002
LSU Health Sciences Center/University Hospital and Clinics (Lafayette)Residency, Internal Medicine, 1997 - 1999
University Karlovy, Lek Fak IiClass of 1981

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2000 - 2028
LA State Medical License 1999 - 2027
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016-2017

Clinical Trials

Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2008 Jul 09
COMPLETED
PHASE2
Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL Start of enrollment: 2012 Mar 30
COMPLETED
PHASE2
Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly
WITHDRAWN
NA

Publications & Presentations

PubMed

A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.
Hayder Saeed, Melanie Mediavilla Varela, Eva Sahakian, Mahrukh Naqvi, Qianxing Mo
Hematological Oncology. 2026-09-01
Flow cytometric analysis of phenotypes and naïve/memory/effector T-cell subsets of T-cell large granular lymphocytic leukemia.
Haipeng Shao, Ning Dong, Richard Shao, Lubomir Sokol, Ling Zhang
Leukemia & Lymphoma. 2026-08-01
Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization.
Catalina Amador, Julio C Poveda, Ibraheem Mohammed, Alyssa Bouska, Elizabeth Hyjek
American Journal of Clinical Pathology. 2026-05-05

Journal Articles

Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 Study
Michael S Khodadoust, Pierluigi Porcu, Francine Foss, Andrei R Shustov, Satish Shanbhag, Lubomir Sokol, Steven M Horwitz, Elad Sharon, European Journal of Cancer

Abstracts/Posters

Use of Lenalidomide Plus Rituximab in TP53-Mutated Mantle Cell Lymphoma (MCL) Outside of Clinic Trial: The Moffitt Experience
Lubomir Sokol, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Bnz-1, a Selective _-Chain Cytokine Inhibitor Has Clinical Activity in Patients with Cutaneous T Cell Lymphoma By Selectively Blocking IL-2, IL-15 and IL-9 Signaling: ...
Lubomir Sokol, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Blockade of IL-15 Utilizing Bnz-1, a Selective _-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemi...
Lubomir Sokol, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 StudyAugust 2018

Press Mentions

Hospitalization Outcomes in Patients with CTCL: A Multi-Center StudyMarch 26th, 2022
Poster Awards Announced Ahead of 2022 Meeting in BostonMarch 7th, 2022
Potential New Drug Target to Treat Cutaneous T Cell LymphomaDecember 21st, 2020

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment